Profusa, Inc. (PFSA) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Profusa, Inc. (PFSA) closed at USD 1.28 on 2026-10-14, a change of -99.9 % over the past year, with a market capitalization of USD 648,042.

Profusa, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Profusa, Inc. key figures

Previous close

USD 1.28 (2026-10-14)

1-year change

-99.9 %

Market cap

USD 648,042

Enterprise value

USD 14.03M

P/E ratio (trailing)

0.00

P/E ratio (forward)

n/a

EPS (trailing)

739.54

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-0.01

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.03

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Profusa, Inc.

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Profusa, Inc. and compare it with other stocks.